Open-label Study to Assess Reduction of Background Asthma Medication While Sustaining Asthma Control and Clinical Remission With Tezepelumab in Patients 12-80yrs With Severe Asthma.
Clinical trial NCT06473779 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06473779
- Sponsor
- AstraZeneca
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-30
- Primary completion
- 2027-06-25
- Enrollment
- 326
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.